Trial Profile
Clinical Trials Insight: 700026913
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2007
Price :
$35
*
At a glance
- Drugs NGX 267 (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors TorreyPines Therapeutics Inc
- 13 Sep 2007 New trial record.